期刊文献+

化瘀三芪丹对2型糖尿病血脂异常及胰岛素敏感性的影响 被引量:6

The Influence of Huayu Sanqi Dan on Blood - Lipid Disorder and Insulin Sensitivity in Type 2 Diabetes Mellitus
下载PDF
导出
摘要 目的:观察化瘀三芪丹对2型糖尿病血脂异常及胰岛素敏感性的影响。方法:将85例2型糖尿病合并血脂异常患者随机分为治疗组57例和对照组28例。2组病例均控制糖尿病饮食及低脂饮食并采用口服磺脲类降糖药物治疗,治疗组加用化瘀三芪丹治疗。观察治疗前后血脂及胰岛素敏感指数的变化。结果:治疗组血脂异常和胰岛素敏感性均有明显改善。结论:化瘀三芪丹能调节2型糖尿病患者血脂异常,并可能通过改善脂代谢紊乱提高机体胰岛素敏感性。 Objective: To observe the influence of Huayu Sanqi Dan (HSD) on blood-lipid disorder and insulin sensitivity in type 2 diabetes mellitus (DM). Methods: 85 cases of type 2 DM complicated with blood - lipid disorder were allocated to treatment group (57 cases) and control group (28 cases) randomly. Diet control, low fat diet and sulfonamides were given in both groups, and added with HSD in the treatment group. Blood - lipids and insulin sensitivity indexes were observed before and after teamtent. Results: The blood - lipid disorder and insulin sensitivity were markedly improved in the treatment group. Conclusion: HSD can modulate the blood - lipid disorder in type 2 DM, and the enhancement of insulin sensitivity is probably responsible for the improvement of blood -lipid metabolism.
作者 汪何
出处 《新中医》 CAS 北大核心 2004年第7期33-34,共2页 New Chinese Medicine
关键词 2型糖尿病 中西医结合疗法 化瘀三芪丹 脂蛋白类 血液 胰岛素敏感性 type 2 diabetes mellitus therapy, TCM combined with western medicine Huayu Sanqi Dan lipoproteins blood insulin sensitivity.
  • 相关文献

参考文献4

二级参考文献6

  • 1杨文英,邢小燕,林红,马晓华,胡英华,李光伟,潘孝仁.高甘油三酯血症是非胰岛素依赖型糖尿病发病的危险因素──432例非糖尿病人群六年前瞻性观察[J].中华内科杂志,1995,34(9):583-586. 被引量:143
  • 2Executive Summary of the Third Report of the National Cholesterol Education Program(NCEP) Expert Panel on Detection. Evaluation and Treatment of High Blood Cholesterol in Adults(Adult Treatment Panel Ⅲ ). JAMA, 2001,285 : 2486.
  • 3American Diabetes Association. Management of dyslipidemia in adults with diabetes (Position Statement). Diabetes Care, 2002,25 (Suppl 1): S74.
  • 4Turner RC, Millns H, Nell HAH, et al. For the United Kingdom Prospective Diabetes Study Group. Risk factors for coronary artery disease in non -insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23).BMJ, 1998,316:823.
  • 5Athyros VG, Papageorgiou AA, Athyrou VV, et al. Atrovastatin and micronized fenofibrate alone and in combination in type 2 diabetes with combined hyperlipidemia. Diabetes Care, 2002, 25:1198.
  • 6刘彦君,许樟荣,张建中,李新元,崔学林,柏文田,赵德明,杨晋德,王玉珍.糖耐量减低的OLETF大鼠胰腺结构和功能改变与糖及脂代谢的关系[J].中华医学杂志,2000,80(3):175-177. 被引量:8

共引文献2668

同被引文献74

引证文献6

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部